Immage Biotherapeutics Corp Stock EBITDA
Immage Biotherapeutics Corp fundamentals help investors to digest information that contributes to Immage Biotherapeutics' financial success or failures. It also enables traders to predict the movement of Immage Stock. The fundamental analysis module provides a way to measure Immage Biotherapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Immage Biotherapeutics stock.
Immage |
Immage Biotherapeutics Corp Company EBITDA Analysis
Immage Biotherapeutics' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Immage Biotherapeutics EBITDA | (1.82 M) |
Most of Immage Biotherapeutics' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Immage Biotherapeutics Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, Immage Biotherapeutics Corp reported earnings before interest,tax, depreciation and amortization of (1.82 Million). This is much lower than that of the sector and significantly lower than that of the EBITDA industry. The ebitda for all United States stocks is notably higher than that of the company.
Immage EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Immage Biotherapeutics' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Immage Biotherapeutics could also be used in its relative valuation, which is a method of valuing Immage Biotherapeutics by comparing valuation metrics of similar companies.Immage Biotherapeutics is currently under evaluation in ebitda category among its peers.
Immage Fundamentals
| Return On Equity | -11.34 | |||
| Return On Asset | -4.96 | |||
| Current Valuation | 32.93 K | |||
| Shares Outstanding | 151.74 M | |||
| Shares Owned By Insiders | 69.85 % | |||
| Price To Earning | (0.01) X | |||
| EBITDA | (1.82 M) | |||
| Net Income | (216.48 K) | |||
| Cash And Equivalents | 53.69 K | |||
| Debt To Equity | 2.52 % | |||
| Current Ratio | 0.83 X | |||
| Cash Flow From Operations | (215.82 K) | |||
| Earnings Per Share | (0.01) X | |||
| Beta | 56.14 | |||
| Market Capitalization | 151 | |||
| Total Asset | 243.1 K | |||
| Working Capital | 17 K | |||
| Current Asset | 75 K | |||
| Current Liabilities | 58 K | |||
| Z Score | -24.62 | |||
| Net Asset | 243.1 K |
About Immage Biotherapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Immage Biotherapeutics Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immage Biotherapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immage Biotherapeutics Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in Immage Stock
If you are still planning to invest in Immage Biotherapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Immage Biotherapeutics' history and understand the potential risks before investing.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |